UK think-tank calls for genetic testing strategy
This article was originally published in Clinica
The UK National Health Service (NHS) has been criticised for failing to set out a coherent strategy for the provision of genetic testing and counselling. A report from the Institute for Public Policy Research (IPPR), a centre-left think-tank, has warned that the NHS will not be able to meet future demand for genetic services.
You may also be interested in...
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.
UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.